ADAR1 Capital Management’s Avalo Therapeutics AVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$523K Buy
104,730
+94,730
+947% +$473K 0.08% 111
2025
Q1
$80.1K Buy
+10,000
New +$80.1K 0.01% 165
2024
Q2
Sell
-6,000
Closed -$131K 249
2024
Q1
$131K Buy
+6,000
New +$131K 0.03% 125